
PLSE
Pulse Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
PLSE Profile
Pulse Biosciences, Inc.
A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors
Healthcare Equipment and Supplies
05/19/2014
05/18/2016
NASDAQ Stock Exchange
75
12-31
Common stock
3957 Point Eden Way, Hayward, CA 94545
--
Pulse Biosciences, Inc., incorporated in Nevada on May 19, 2014 under the name Electroblate, Inc., is a medical device company using a new and proprietary platform technology, nano-pulsed electrical signaling, or NPES in the developmental stage of biomedical applications. Electroblate, Inc., was renamed Pulse Biosciences Corporation, effective December 8, 2015.